| Literature DB >> 30209712 |
Corinne Schaub1, Armin Von Gunten2, Diane Morin3,4, Pascal Wild5,6, Patrick Gomez5, Julius Popp2,7.
Abstract
Agitation in people with dementia is a growing concern as it causes distress for both patients and their nurses and may contribute to relational disorders. Previous studies involving patients with dementia living in long-term care facilities have reported decreased agitation following massage. The objective of this pilot study was to investigate the effect of hand massage on agitation and biological markers of stress in patients with dementia hospitalized in an acute geriatric psychiatry service. In this randomized controlled trial we included 40 agitated patients with dementia with an intervention group and a control group. The study is designed to test the effect of seven hand massages over three continuous weeks on agitation and levels of salivary cortisol (sC) and alpha-amylase (sAA). Compared to the control group, the intervention group exhibited larger increases in sC and sAA at week 1 from before to after the massage, but larger decreases at week 2 and 3, with a significant group effect for sAA at week 2. Agitation scores were not significantly different between the groups but tended to decrease more in the intervention group than the control group. This study provides first encouraging results suggesting that hand massage might have beneficial effects on stress and agitation in hospitalized patients with dementia. It also highlights the challenges associated with conducting such studies with this complex patient population. Further studies are needed to confirm these findings and the benefits of hand massage as part of routine care for patients with dementia.Entities:
Keywords: Agitation; Dementia; Hand massage; Salivary biomarkers; Stress
Mesh:
Substances:
Year: 2018 PMID: 30209712 PMCID: PMC6223738 DOI: 10.1007/s10484-018-9416-2
Source DB: PubMed Journal: Appl Psychophysiol Biofeedback ISSN: 1090-0586
Demographic and health-related characteristics of the sample at baseline (T0)
| Characteristics | Intervention (n = 20) | Control (n = 20) |
|
|---|---|---|---|
| Gender (n; %) | |||
| Male | 9 (45%) | 11 (55%) | |
| Female | 11 (55%) | 9 (45%) |
|
| Age (years: M; SD) | 81.15 (12.75) | 83.14 (4.72) |
|
| Length of hospital stay (days: M; SD) | 25.00 (26.24) | 31.76 (22.99) |
|
| CDR scores (n) | |||
| Score = 1 | 1 | 6 | |
| Score = 2 | 16 | 9 | |
| Score = 3 | 3 | 5 |
|
| HoNOS65+ score (n) | |||
| Score = 1 | 1 | 2 | |
| Score = 2 | 5 | 4 | |
| Score = 3 | 8 | 11 | |
| Score = 4 | 6 | 3 |
|
| Medication (n) | |||
| Analgesics | 11 | 10 |
|
| Hypnotics | 13 | 15 |
|
| Antidepressants | 10 | 14 |
|
| Neuroleptics | 18 | 13 |
|
Tests applied: §: Pearson chi2 ∫: Wilcoxon ♯: Fischer exact
Fig. 1Study process
Fig. 2Enrollment and follow up
Means (SDs) of sC, sAA, and CMAI for the intervention and control groups
| sC (nmol/L) | sAA (U/mL) | CMAI | ||||
|---|---|---|---|---|---|---|
| Intervention | Control | Intervention | Control | Intervention | Control | |
| Week T1 | ||||||
| T11 | 16.74 (11.31) | 17.55 (6.58) | 278.68 (167.05) | 304.03 (418.02) | 3.5 (4.9) | 2.3 (3.3) |
| T12 | 14.00 (7.73) | 18.42 (7.16) | 292.92 (178.66) | 279.76 (221.18) | ||
| T13 | 15.85 (6.41) | 18.05 (7.25) | 335.91 (202.88) | 308.43 (330.10) | ||
| T14 | 3.4 (4.5) | 4.3 (4.2) | ||||
| Week T2 | ||||||
| T21 | 14.00 (7.73) | 18.78 (6.79) | 287.13 (168.19) | 286.89 (376.62) | 4.2 (4.8) | 2.6 (4.2) |
| T22 | 21.19 (12.24) | 15.17 (5.57) | 292.18 (168.94) | 317.84 (326.83) | ||
| T23 | 15.85 (6.41) | 17.04 (7.08) | 229.96 (138.47) | 345.07 (363.90) | ||
| T24 | 3.9 (4.9) | 4.5 (4.3) | ||||
| Week T3 | ||||||
| T31 | 15.54 (9.74) | 17.72 (9.18) | 356.10 (205.46) | 234.26 (184.64) | 3.1 (3.8) | 3.2 (4.0) |
| T32 | 14.75 (7.98) | 18.83 (9.20) | 345.80 (199.47) | 267.43 (190.67) | ||
| T33 | 12.89 (7.06) | 16.32 (7.98) | 291.80 (114.59) | 251.15 (144.38) | ||
| T34 | 4.6 (5.9) | 4.0 (4.3) | ||||
sC salivary cortisol, sAA salivary alpha-amylase, CMAI total agitation. T11 = 2 p.m.; T12 = 2.20 p.m., T13 = 2.40 p.m., T14 = 5 p.m. (same for each week)
Fig. 3Estimated models for salivary cortisol and alpha-amylase. There are three measures for each week (T1, T2, and T3), i.e.: T1 2.00 = Week 1 at 2 p.m., T2 2.20 = Week 2 at 2.20 p.m., T3 2.40 = Week 3 at 2.40 p.m.
Means (SDs) of change scores for log-transformed sC and sAA with t-values and ds of the group effect
| sC | sAA | |||||||
|---|---|---|---|---|---|---|---|---|
| Intervention | Control |
|
| Intervention | Control |
|
| |
| Week 1 (T1) | ||||||||
| T12 − T11 | − 0.006 (0.106) | − 0.007 (0.106) |
| − 0.01 | 0.058 (0.195) | 0.011 (0.264) |
| − 0.20 |
| T13 − T12 | 0.006 (0.063) | − 0.011 (0.109) |
| − 0.19 | 0.065 (0.167) | − 0.041 (0.190) |
| − 0.59 |
| T13 − T11 | 0.015 (0.126) | 0.000 (0.144) |
| − 0.11 | 0.123 (0.175) | 0.030 (0.288) |
| − 0.39 |
| Week 2 (T2) | ||||||||
| T22 − T21 | 0.056 (0.214) | − 0.088 (0.180) |
| − 0.73 | 0.039 (0.170) | 0.044 (0.311) |
| 0.02 |
| T23 − T22 | − 0.099 (0.166) | 0.044 (0.146) |
| 0.92 | − 0.114 (0.150) | 0.090 (0.207) |
| 1.13 |
| T23 − T21 | − 0.043 (0.114) | − 0.039 (0.110) |
| 0.03 | − 0.075 (0.120) | 0.110 (0.192) |
| 1.15 |
| Week 3 (T3) | ||||||||
| T32 − T31 | − 0.006 (0.087) | 0.017 (0.091) |
| 0.26 | − 0.049 (0.322) | 0.118 (0.281) |
| 0.55 |
| T33 − T32 | − 0.044 (0.070) | − 0.031 (0.126) |
| 0.13 | 0.038 (0.292) | − 0.062 (0.244) |
| − 0.37 |
| T33 − T31 | − 0.060 (0.095) | − 0.010 (0.157) |
| 0.39 | − 0.021 (0.197) | 0.048 (0.246) |
| 0.31 |
sC salivary cortisol, sAA salivary alpha-amylase. There are three measures for each week (T1, T2, and T3), i.e.: T1:T11 = 2 pm, T12 = 2.20 pm, T13 = 2.40 pm
*p < 0.05; **p < 0.01
Means (SDs) of change scores for CMAI and subscales of agitation with t-values and ds of the group effect
| Intervention | Control |
|
| |
|---|---|---|---|---|
| Week 1 (T14 − T11) | ||||
| CMAI | − 0.1(4.2) | 2.0(4.5) |
| 0.49 |
| PA | − 0.1(0.3) | 0.1(0.2) |
| 0.55 |
| PN | 0.7(2.8) | 1.9(3.1) |
| 0.40 |
| VA | − 0.3(0.6) | 0.1(1.9) |
| 0.31 |
| VN | − 0.5(2.3) | − 0.1(2.7) |
| 0.13 |
| Week 2 (T24 − T21) | ||||
| CMAI | − 0.3(5.9) | 1.7(4.1) |
| 0.39 |
| PA | − 0.1(0.2) | − 0.2(0.6) |
| − 0.34 |
| PN | 0.2(5.1) | 1.3(3.5) |
| 0.23 |
| VA | − 0.2(1.2) | − 0.3(1.3) |
| − 0.13 |
| VN | − 0.2(2.8) | 1.1(2.3) |
| 0.48 |
| Week 3 (T34 − T31) | ||||
| CMAI | 1.5(6.1) | 0.7(5.6) |
| − 0.14 |
| PA | 0.0(0.0) | − 0.2(0.7) |
| − 0.36 |
| PN | 1.3(4.5) | 1.1(5.0) |
| − 0.05 |
| VA | 0.5(2.7) | 0.7(1.2) |
| 0.09 |
| VN | − 0.3(2.3) | − 0.8(2.7) |
| − 0.21 |
CMAI total agitation score, PA physically aggressive agitation, PN physically non-aggressive agitation, VA verbally aggressive agitation, VN verbally non-aggressive agitation. There are two measures for each week (T1, T2, T3), i.e., T1:T11 = 2 pm, T14 = 5 p.m.
ap = 0.08